Millipore Sigma Vibrant Logo

203820 Guanosine 3ʹ,5ʹ-cyclic Monophosphate, 8-Bromo-, Sodium Salt - CAS 51116-01-9 - Calbiochem

Cell-permeable cGMP analog that is more resistant to phosphodiesterases than cGMP.

FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.

Synonymes: 8-Bromo-cGMP, Br-cGMP, Na

Primary Target: protein kinase G
View Products on Sigmaaldrich.com
203820
Voir les Prix & la Disponibilité

Aperçu

Replacement Information

Tableau de caractéristiques principal

CAS #Empirical Formula
51116-01-9C₁₀H₁₀BrN₅O₇P · Na

Prix & Disponibilité

Référence DisponibilitéConditionnement Qté Prix Quantité
203820-25MG
Récupération des données relatives à la disponibilité...
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      		 Ampoule plast. 25 mg
      Prix en cours de récupération
      Le prix n'a pas pu être récupéré
      La quantité minimale doit être un multiple de
      Maximum Quantity is
      À la validation de la commande Plus d'informations
      Vous avez sauvegardé ()
       
      —
      Demander le prix
      		 —
      Description
      OverviewCell-permeable cGMP analog that is more resistant to phosphodiesterases than cGMP. Preferentially activates protein kinase G. Inhibits thrombin-stimulated arachidonic acid release in human platelets.
      Catalogue Number203820
      Brand Family Calbiochem®
      Synonyms8-Bromo-cGMP, Br-cGMP, Na
      References
      ReferencesKwak, B.R., and Jongsma, H.J. 1996. Mol. Cell. Biochem. 157, 93.
      Perreault, T., and DeMarte, J. 1993. Am. J. Physiol. 264, H302.
      Ruth, P., et al. 1991. Eur. J. Biochem. 202, 1339.
      Schwarzschild, M.A., and Zigmond, R.E. 1991. J. Neurochem. 56, 400.
      Product Information
      CAS number51116-01-9
      ATP CompetitiveN
      FormWhite solid
      Hill FormulaC₁₀H₁₀BrN₅O₇P · Na
      Chemical formulaC₁₀H₁₀BrN₅O₇P · Na
      Hygroscopic Hygroscopic
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary Targetprotein kinase G
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Protect from Moisture Protect from moisture
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Aqueous stock solutions are stable for up to 1 week at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      203820-25MG 04055977204032

      Documentation

      Guanosine 3ʹ,5ʹ-cyclic Monophosphate, 8-Bromo-, Sodium Salt - CAS 51116-01-9 - Calbiochem FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      Guanosine 3ʹ,5ʹ-cyclic Monophosphate, 8-Bromo-, Sodium Salt - CAS 51116-01-9 - Calbiochem Certificats d'analyse

      TitreNuméro de lot
      203820

      Références bibliographiques

      Aperçu de la référence bibliographique
      Kwak, B.R., and Jongsma, H.J. 1996. Mol. Cell. Biochem. 157, 93.
      Perreault, T., and DeMarte, J. 1993. Am. J. Physiol. 264, H302.
      Ruth, P., et al. 1991. Eur. J. Biochem. 202, 1339.
      Schwarzschild, M.A., and Zigmond, R.E. 1991. J. Neurochem. 56, 400.

      Citations

      Titre
    • Bing Zhu, Samuel Strada and Troy Stevens. (2005) Cyclic GMP-specific phosphodiesterase 5 regulates growth and apoptosis in pulmonary endothelial cells. American Journal of Physiology Lung Cellular and Molecular Physiology 289, L196-L206.
      		•
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision22-May-2008 RFH
      Synonyms8-Bromo-cGMP, Br-cGMP, Na
      DescriptionCell-permeable cGMP analog that is more resistant to phosphodiesterases than cGMP. Preferentially activates protein kinase G. Inhibits thrombin-stimulated arachidonic acid release in human platelets.
      FormWhite solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number51116-01-9
      Chemical formulaC₁₀H₁₀BrN₅O₇P · Na
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityH₂O (200 mg/ml)
      Storage Protect from moisture
      -20°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Aqueous stock solutions are stable for up to 1 week at -20°C.
      Toxicity Standard Handling
      ReferencesKwak, B.R., and Jongsma, H.J. 1996. Mol. Cell. Biochem. 157, 93.
      Perreault, T., and DeMarte, J. 1993. Am. J. Physiol. 264, H302.
      Ruth, P., et al. 1991. Eur. J. Biochem. 202, 1339.
      Schwarzschild, M.A., and Zigmond, R.E. 1991. J. Neurochem. 56, 400.
      Citation
    • Bing Zhu, Samuel Strada and Troy Stevens. (2005) Cyclic GMP-specific phosphodiesterase 5 regulates growth and apoptosis in pulmonary endothelial cells. American Journal of Physiology Lung Cellular and Molecular Physiology 289, L196-L206.
      		•